EVALUATION OF THE EFFECTIVENESS OF URINARY KALLIDINOGENASE (TISSUE KALLIKRIEN) IN THE COMPLEX THERAPY OF PATIENTS WITH ISOLATED CLOSED TRAUMATIC BRAIN INJURY

dc.contributor.author	Kenjaev L.T.
dc.date.accessioned	2025-12-31T15:36:26Z
dc.date.issued	2022-09-20
dc.description.abstract	Closed traumatic brain injury is quite common and affects millions of people worldwide every year. In the structure of injuries, the most dramatic is traumatic brain injury. In the European Union, up to 1.5 million people are hospitalized, 57,000 die every year due to TBI and three-quarters of them are young people. Kallidinogenase - tissue kallikrein, a component of the kallikrein - kinin system (KKS), has a protective effect against cerebral ischemia.
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbph/article/view/1392
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/49078
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbph/article/view/1392/1237
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Public Health; Vol. 14 (2022): WBPH; 69-74
dc.source	2749-3644
dc.subject	TBI
dc.subject	tissue kallikrein
dc.subject	ICP
dc.subject	CPP
dc.title	EVALUATION OF THE EFFECTIVENESS OF URINARY KALLIDINOGENASE (TISSUE KALLIKRIEN) IN THE COMPLEX THERAPY OF PATIENTS WITH ISOLATED CLOSED TRAUMATIC BRAIN INJURY
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: lt_2022_evaluation_of_the_effectiveness_of_urina.pdf
item.page.filesection.size: 168.05 KB
item.page.filesection.format: Adobe Portable Document Format